Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-05-02 | 2022-04-13 |
| Drug Identification Number | 02465833 | 02465833 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | Piperacillin and Tazobactam for Injection | Piperacillin and Tazobactam for Injection |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | TAZOBACTAM PIPERACILLIN | TAZOBACTAM PIPERACILLIN |
| Strength(s) | 4.5G 36G | 4.5G 36G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 200 mL | 200 mL |
| ATC code | J01CR | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2022-01-10 | 2022-01-10 |
| Estimated end date | 2022-04-30 | 2022-04-30 |
| Actual end date | 2022-04-30 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | On 100% allocation | On 100% allocation |
| Health Canada comments |